McCarthy B D, Yood M U, Boohaker E A, Ward R E, Rebner M, Johnson C C
Division of General Internal Medicine, Henry Ford Health System, Detroit, Michigan 48202, USA.
Am J Prev Med. 1996 Jul-Aug;12(4):282-8.
Routine mammographic screening increases detection of nonpalpable breast cancer. Timely follow-up of abnormalities is essential because delays may lead to postponement of treatment and decreased survival for women who have cancer. The purpose of this study was to determine the percentage of women with an abnormal mammogram who do not have adequate follow-up and to determine factors associated with inadequate follow-up. The study was conducted in a metropolitan health system that includes a large urban teaching hospital in Detroit and 26 ambulatory care centers. From the radiology database, all women with an abnormal screening mammogram performed between January 1, 1992, and July 31, 1992 were identified. We defined adequate follow-up as follow-up within three months of due date. Follow-up status was determined using medical records and telephone interviews. The percentage of women with inadequate follow-up was calculated. Relative risks compared percentages of women with inadequate follow-up according to demographic and screening-related variables. We calculated adjusted relative risks using multivariate binomial regression. We identified 1,249 women with abnormal screening mammograms. Inadequate follow-up occurred for 226 (18.1%) of the women. Among women with follow-up recommended in 4-6 months, 36.8% had inadequate follow-up. Among women with immediate follow-up recommended (obtain additional views or outside films for comparison, ultrasound, biopsy, or surgical referral), 7.2% had inadequate follow-up. Inadequate follow-up was associated with lower estimated household income and no history of previous mammogram. Among women with inadequate follow-up who were interviewed, 87% reported that they had been notified of their results. We found that the percentage of women with inadequate follow-up of abnormal mammograms is high, especially among women who require six-month follow-up. Women with low income and no history of a previous mammogram were at greatest risk for inadequate follow-up. These results document a previously unrecognized problem with mammography screening and suggest that the implementation of tracking systems to ensure timely follow-up of abnormal screening mammograms is essential. Medical Subject Headings (MeSH): mammography, follow-up, screening.
常规乳腺钼靶筛查可提高不可触及乳腺癌的检出率。对异常情况进行及时随访至关重要,因为延迟可能导致治疗推迟,并降低患癌女性的生存率。本研究的目的是确定乳腺钼靶检查异常的女性中未进行充分随访的比例,并确定与随访不充分相关的因素。该研究在一个大都市卫生系统中进行,该系统包括底特律的一家大型城市教学医院和26个门诊护理中心。从放射学数据库中,识别出1992年1月1日至1992年7月31日期间进行乳腺钼靶筛查且结果异常的所有女性。我们将充分随访定义为在应随访日期的三个月内进行随访。通过查阅病历和电话访谈来确定随访状态。计算未进行充分随访的女性比例。相对风险比较了根据人口统计学和筛查相关变量未进行充分随访的女性百分比。我们使用多变量二项式回归计算调整后的相对风险。我们识别出1249名乳腺钼靶筛查结果异常的女性。其中226名(18.1%)女性随访不充分。在建议4 - 6个月后随访的女性中,36.8%随访不充分。在建议立即随访(获取额外影像或外部影像进行对比、超声检查、活检或手术转诊)的女性中,7.2%随访不充分。随访不充分与估计家庭收入较低以及既往无乳腺钼靶检查史有关。在接受访谈的随访不充分的女性中,87%报告称已被告知检查结果。我们发现乳腺钼靶检查异常的女性中随访不充分的比例很高,尤其是在需要六个月随访的女性中。低收入且既往无乳腺钼靶检查史的女性随访不充分的风险最大。这些结果记录了乳腺钼靶筛查中一个此前未被认识到的问题,并表明实施跟踪系统以确保对乳腺钼靶筛查异常情况进行及时随访至关重要。医学主题词(MeSH):乳腺钼靶摄影、随访、筛查。